Addiction and obesity share similar neurological pathways, both linked to compulsive behaviors and the brain's reward system. Research has highlighted the potential of GLP-1 receptor agonists, originally developed for diabetes, to help manage both appetite and addictive cravings. These medications, such as semaglutide, may regulate addictive behaviors by influencing reward circuits in the brain. However, they come with potential side effects, and their long-term effects are still under investigation.

In addition, a new compound, 5-Methoxy-2-aminoindane (MEAI), is being researched for its...

Individuals with chronic pain are more likely to engage in hazardous alcohol use compared to the general population. Despite this increased risk, they are an underserved group regarding targeted interventions. There is a pressing need to explore and develop alternative strategies to effectively reduce hazardous drinking in this vulnerable population. One promising approach is to focus on managing pain-related anxiety, which is a potential mechanism linked to hazardous drinking.

Researchers adopted a phased model (1A/1B) to address this need to create and test a new personalized feedback...

Co-morbidity or dual diagnosis is established by the World Health Organization (WHO) as the 'co-occurrence in the same individual of a dysfunction of psychoactive substance use and other psychiatric disorder' (WHO, 1995). There is a growing feeling on the part of psychologists and other professionals working in the treatment of addictive behaviors, that there is a high occurrence of not characterized psychopathological problems with implications for the treatment of drug addicts. Resulting from this observation and the need felt in clinical practice, the Regional Delegation of the Alentejo...